749 related articles for article (PubMed ID: 25468385)
1. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
[TBL] [Abstract][Full Text] [Related]
2. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
[TBL] [Abstract][Full Text] [Related]
3. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
[TBL] [Abstract][Full Text] [Related]
4. Evaluating warfarin management by pharmacists in a community teaching hospital.
Chilipko AA; Norwood DK
Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
[TBL] [Abstract][Full Text] [Related]
5. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
Abadi U; Ellis MH
Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
[TBL] [Abstract][Full Text] [Related]
6. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
[TBL] [Abstract][Full Text] [Related]
8. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Over-Anticoagulation in Warfarin Users in the UK General Population: A Nested Case-Control Study in a Primary Health Care Database.
Martín-Pérez M; Gaist D; de Abajo FJ; García Rodríguez LA
Thromb Haemost; 2019 Jan; 119(1):66-76. PubMed ID: 30597501
[TBL] [Abstract][Full Text] [Related]
10. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
11. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
Garcia DA; Regan S; Crowther M; Hylek EM
J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
[TBL] [Abstract][Full Text] [Related]
12. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.
Kucher N; Connolly S; Beckman JA; Cheng LH; Tsilimingras KV; Fanikos J; Goldhaber SZ
Arch Intern Med; 2004 Oct; 164(19):2176-9. PubMed ID: 15505133
[TBL] [Abstract][Full Text] [Related]
13. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.
Hirai T; Hamada Y; Geka Y; Kuwana S; Hirai K; Ishibashi M; Fukaya Y; Kimura T
Eur J Clin Pharmacol; 2017 Nov; 73(11):1491-1497. PubMed ID: 28795244
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
Perona S; Ford M; Rindone J
J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
[TBL] [Abstract][Full Text] [Related]
16. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
Fang MC; Chang Y; Hylek EM; Rosand J; Greenberg SM; Go AS; Singer DE
Ann Intern Med; 2004 Nov; 141(10):745-52. PubMed ID: 15545674
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
18. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
[TBL] [Abstract][Full Text] [Related]
19. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]